立体定向体部放疗的采用对前列腺癌治疗模式的影响
该研究利用SEER-Medicare数据识别2007至2011年确诊的前列腺癌男性,构建344个医生-医院网络,分析立体定向体部放疗(SBRT)是否在网络中开展与治疗分布的关系。结果显示,开展与未开展SBRT的网络在机器人前列腺切除术、根治性前列腺切除术和主动监测的使用上随时间无差异(均p>0.05),但开展SBRT的网络近距离放疗率更低(p=0.03)。作者认为SBRT可能更多是近距离放疗的替代,而非主动监测的替代。
要点
- 开展与未开展SBRT的网络在机器人前列腺切除术、根治性前列腺切除术和主动监测的使用上随时间无差异(均p>0.05)。
- 开展SBRT的网络近距离放疗率更低(p=0.03)。
- 作者认为SBRT可能更多是近距离放疗的替代,而非主动监测的替代。
核心结论
- 开展与未开展SBRT的网络在机器人前列腺切除术、根治性前列腺切除术和主动监测的使用上随时间无差异(均p>0.05),但开展SBRT的网络近距离放疗率更低(p=0.03)。
- 作者认为SBRT可能更多是近距离放疗的替代,而非主动监测的替代。
研究设计与样本
- 利用SEER-Medicare数据库识别2007至2011年确诊的前列腺癌男性,基于主要治疗确定每位患者的治疗医生,并将医生分配到医院,构建医生-医院网络。
- 共识别344个医生-医院网络,其中30个(8.7%)开展SBRT,314个(91.3%)未开展SBRT。
- 拟合带稳健标准误的逻辑回归模型,以考虑患者在网络中的聚类。
主要发现
- 开展与未开展SBRT的网络在机器人前列腺切除术、根治性前列腺切除术和主动监测的使用上随时间无差异(均p>0.05)。
- 与调强放疗的关系未显示一致的时间模式;开展SBRT的网络初期调强放疗较少,但后期年份率相似。
- 开展与未开展SBRT的网络近距离放疗趋势不同,开展SBRT的网络近距离放疗率更低(p=0.03)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To our knowledge it is unknown whether stereotactic body radiation therapy of prostate cancer is a substitute for other radiation treatments or surgery, or for expanding the pool of patients who undergo treatment instead of active surveillance. MATERIALS AND METHODS: Using SEER (Surveillance, Epidemiology, and End Results)-Medicare we identified men diagnosed with prostate cancer between 2007 and 2011. We developed physician-hospital networks by identifying the treating physician of each patient based on the primary treatment received and subsequently assigning each physician to a hospital. We examined the relative distribution of prostate cancer treatments stratified by whether stereotactic body radiation therapy was performed in a network by fitting logistic regression models with robust SEs to account for patient clustering in networks. RESULTS: We identified 344 physician-hospital networks, including 30 (8.7%) and 314 (91.3%) in which stereotactic body radiation therapy was and was not performed, respectively. Networks in which that therapy was and was not done did not differ with time in the performance of robotic and radical prostatectomy, and active surveillance (all p >0.05). The relationship with intensity modulated radiation therapy did not show any consistent temporal pattern. In networks in which it was performed less intensity modulated radiation therapy was initially done but there were similar rates in later years. Brachytherapy trends differed among networks in which stereotactic body radiation therapy was vs was not performed with a lower brachytherapy rate in networks in which stereotactic body radiation therapy was done (p=0.03). CONCLUSIONS: Surgery and active surveillance rates did not differ in networks in which stereotactic body radiation therapy was vs was not performed but when that therapy was done there was a lower brachytherapy rate. Stereotactic body radiation therapy may represent more of an alternative to brachytherapy than to active surveillance.
引用
- Jacobs BL, Yabes JG, Lopa SH, et al. The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns. J Urol. 2019. PMID: 31361571. doi:10.1097/JU.0000000000000471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。